Corbenic Partners LLC Gilead Sciences, Inc. Transaction History

Corbenic Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$64.88 - $73.64 $3,244 - $3,682	-50 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $1,416 - $1,613	-25 Reduced 33.33%	50 $3,000
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $4,697 - $6,016	75 New	75 $6,000
Q4 2017 Jan 25, 2018	SELL	$71.15 - $83.52 $1,067 - $1,252	-15 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $1,081 - $1,282	15	15 $1,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Corbenic Partners LLC with notifications on news.